Tag Archives: Anti-MAG Autoantibodies ELISA

Rapid Worsening of IgM Anti-MAG Demyelinating Polyneuropathy During Rituximab Treatment

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment. J Peripher Nerv Syst. 2013 Jun; 18(2):189-91. PMID:23781968

Continue Reading →

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Sala E et al.; Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy. J Neurol Sci. 2014 Oct 15; 345(1-2):224-7. PMID:25115501  

Continue Reading →

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Magy L et al.; Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies; J Immunol Res. 2015;2015: 450391. doi: 10.1155/2015/450391. Epub 2015 May 6. PMID:26065001

Continue Reading →

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381

Continue Reading →